MedicineMRP Under Process
Official PMBI MRP is being updated for catalog code 2875.
Locate Jan Aushadhi KendraClinical Overview
Ketoprofen Transdermal Patch (30mg) is a propionic acid non-steroidal anti-inflammatory patch. Delivers sustained transdermal release of ketoprofen directly into local subcutaneous tissues, muscles, and joint spaces, inhibiting local cyclooxygenase enzymes and bradykinin generation while maintaining low systemic plasma levels. Indicated for localized treatment of pain and inflammation in osteoarthritis, periarthritis, tendinitis, epicondylitis (tennis elbow), and acute muscle sprains and contusions.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Apply 1 patch to clean, dry, intact skin over the affected joint or muscle once daily. Press edges firmly. Remove after 24 hours and replace with a fresh patch if needed.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Local skin redness, itching, contact dermatitis. Rare/Severe: Severe photoallergic contact dermatitis (photosensitivity triggered by sunlight or UV rays).
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Black Box Warning: Severe photosensitivity and photoallergic contact dermatitis; keep treated areas completely covered and protected from sunlight and UV lamps during application and for 2 weeks after patch removal. Do not apply to eczema, broken skin, or open wounds.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or analgesic treatment guidance. Always consult a registered physician or orthopedic specialist before taking pain relievers, anti-inflammatory medications, or anti-arthritic therapies.
Diclofenac Gel 1.16% (Diclofenac Diethylamine)
Diclofenac Gel 1.16% (Diclofenac Diethylamine) is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.
Diclofenac 1.16%, Linceed Oil 3%, Methyl Salicylate 10% and Menthol 5% Gel
Diclofenac 1.16%, Linceed Oil 3%, Methyl Salicylate 10% and Menthol 5% Gel is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.
Nimesulide Gel 1%
Nimesulide Gel 1% is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.
Diclofenac Dithylamine 1.16%, Linseed Oil 3%, Methyl Salicylate 10% and Menthol 5% Spray
Diclofenac Dithylamine 1.16%, Linseed Oil 3%, Methyl Salicylate 10% and Menthol 5% Spray is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.